Results 1 to 10 of about 9,905 (116)

CALR-dependent endoplasmic reticulum N-glycoprotein maturation promotes Japanese encephalitis virus entry and replication [PDF]

open access: yesCell & Bioscience
The endoplasmic reticulum (ER) chaperone machinery participates in multiple stages of viral infection, from entry through assembly and release. However, how ER-resident quality-control mechanisms shape cellular permissiveness to Japanese encephalitis ...
Yonghui Zhang   +14 more
doaj   +2 more sources

Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm

open access: yesCell Communication and Signaling
Calreticulin (CALR) is an endoplasmic reticulum chaperone. Frameshift mutations in CALR were discovered in patients with myeloproliferative neoplasm showing increased platelet counts.
Saurabh Shrivastva   +2 more
exaly   +2 more sources

Transcriptional regulation of cpsQ-mfpABC and mfpABC by CalR in Vibrio parahaemolyticus

open access: yesMicrobiologyOpen, 2017
The cpsQ‐mfpABC locus is transcribed as two operons, i.e., cpsQ‐mfpABC and mfpABC, in Vibrio parahaemolyticus, and both of them are all required for biofilm formation.
George Osei-Adjei   +2 more
exaly   +2 more sources

Response to therapy and prognosis according to molecular characterization in CALR‐mutated essential thrombocythemia [PDF]

open access: yesHemaSphere
Response to cytoreductive therapy according to CALR mutation type, CALR variant allele frequency (VAF), and additional mutations has not been previously studied in essential thrombocythemia (ET).
Marta Santaliestra   +28 more
doaj   +2 more sources

Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India

open access: yesHematology/Oncology and Stem Cell Therapy, 2022
Objective/Background: Recurrent somatic mutations in the JAK2, calreticulin (CALR), and the MPL genes are described as drivers of BCR-ABL1-negative myeloproliferative neoplasms (MPN) that includes polycythemia vera (PV), essential thrombocytosis (ET ...
Madhavi Maddali   +14 more
doaj   +1 more source

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma

open access: yesFrontiers in Genetics, 2022
Background: Calreticulin (CALR) has been investigated in several malignant diseases and is associated with immune-cell infiltration. However, the prognostic value of CALR in kidney renal clear cell carcinoma (KIRC) is still unknown.Methods: Based on the ...
Ming Sun   +4 more
doaj   +1 more source

High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells

open access: yesBlood Cancer Journal, 2021
Mutations of calreticulin (CALR) are the second most prevalent driver mutations in essential thrombocythemia and primary myelofibrosis. To identify potential targeted therapies for CALR mutated myeloproliferative neoplasms, we searched for small ...
Ruochen Jia   +10 more
doaj   +1 more source

Bioinformatics analysis for the role of CALR in human cancers.

open access: yesPLoS ONE, 2021
Cancer is one of the most important public health problems in the world. The curative effect of traditional surgery, radiotherapy and chemotherapy is limited and has inevitable side effects.
Yijun Li   +6 more
doaj   +1 more source

Doxycycline Induces Apoptosis of Brucella Suis S2 Strain-Infected HMC3 Microglial Cells by Activating Calreticulin-Dependent JNK/p53 Signaling Pathway

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Neurobrucellosis is a chronic complication of human brucellosis that is caused by the presence of Brucella spp in the central nervous system (CNS) and the inflammation play a key role on the pathogenesis.
Zhao Wang   +5 more
doaj   +1 more source

Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice

open access: yesJournal of Hematology & Oncology, 2021
Frameshifts in the Calreticulin (CALR) exon 9 provide a recurrent driver mutation of essential thrombocythemia (ET) and primary myelofibrosis among myeloproliferative neoplasms (MPNs).
Keiji Minakawa   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy